Mandate

Vinge advises Axcel in connection with the acquisition of Progrits, a leading software company in vertical software and information services

Progrits consists of ten businesses that develop specialised solutions within transport and logistics, vehicle digital solutions and integrated e-commerce. The B2B software company simplifies and automates customer information handling and workflows for approximately 5,000 Nordic and international customers.

The acquisition is subject to approval from applicable competition authority.

Vinge’s team consisted of Christina Kokko, Johanna Wiberg, Viktor Lennartsson, Nando Basic and Josef Groow (M&A), Mathilda Persson and Alva Skott (Commercial Agreements), August Ahlin (Banking and Financing), Madelene Andersson (Real Estate), Julia Löfqvist (Compliance), Tove Hallbäck (Employment), Lisa Hörnqvist (IT and GDPR), Arvid Axelryd and Felizia Wiker (Intellectual Property), Sebastian Örndahl, Victoria Fredén and Hampus Peterson (Merger filing) and Ellinore Boström Andersson (Project Assistant).

Related

Vinge advises Atria Sverige in conjunction with an investment in Cookin Food

Atria Sverige has acquired a 25 per cent stake in the Swedish convenience food company Cookin Food Sweden AB. The transaction has been performed through the acquisition of shares in Bite Delight AB, which owns Cookin Food Sweden AB. Atria holds an option to acquire the remaining shares in Bite Delight AB after 2028.
March 04, 2026

Vinge advises Revivo Group on the acquisition of Solidenergy

Revivo Group, a portfolio company of Helix Kapital, has acquired Solidenergy, a leading provider of surface treatment services in the Norwegian market. The company operates within the energy, offshore and infrastructure sectors and is headquartered in Ågotnes outside Bergen. Solidenergy employs approximately 600 people.
March 03, 2026

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a partially guaranteed rights issue which is expected to provide Oncopeptides with proceeds of approximately SEK 200 million before deduction of transaction costs.
March 03, 2026